Our Customers
Products & Pipeline
Science & DTx
For business
Solutions
Clinicians
Investors
About us
Contact us
FacebookTwitterLinkedinYouTube
NHS
US Payers

Corporate Snapshot Compliance

This document is made available for information purposes only and does not, and is not intended to, constitute an offer to sell or an offer, inducement, invitation or commitment to purchase or subscribe for any securities. The distribution of this document may, in certain jurisdictions, be restricted by law and neither it nor any part of it nor the fact of its distribution shall form the basis of or be relied upon in connection with any contract and it does not constitute a recommendation regarding any securities. This document does not purport to contain all of the information that may be required to evaluate any investment in the Company or any of its securities. This document is intended to present background information on the Company, its business and the industry in which it operates and is not intended to provide complete disclosure upon which an investment decision could be made. The merit and suitability of an investment in the Company should be independently evaluated and any person considering such an investment in the Company is advised to obtain independent advice as to legal, tax, accounting and/or financial matters and other related advice prior to making an investment.

Nothing contained in this document shall form the basis of any contract or commitment whatsoever. No representation or warranty is given by or on behalf of the Company or any of such persons' directors, officers, employees or affiliates or any other person (its "Related Parties") as to the fairness, accuracy or completeness of the contents of this document or any other statement made or purported to be made by any of them, or on their behalf, in connection with the Company or any potential transaction. Nothing in this document shall be relied upon as a promise or representation in this respect, whether as to the past or the future. There is no obligation on any person to update this document. No liability whatsoever is accepted by the Company or any of its Related Parties for any loss howsoever arising, directly or indirectly, from any use of this document, the information or opinions contained herein or otherwise arising in connection herewith.

Certain information contained in this document has been obtained from published sources prepared by other parties, which in certain cases have not been updated to the date hereof. While such information is believed to be reliable for the purpose used in this document, each of the Company and its Related Parties do not assume any responsibility for the accuracy or completeness of such information and which has not been independently verified by the Company or its Related Parties. Except where otherwise indicated herein, the information provided in this document is based on matters as they exist as of the date of preparation and not as of any future date, and will not be updated or otherwise revised to reflect information that subsequently becomes available, or circumstances existing or changes occurring after the date hereof.

Certain information contained herein constitutes “forward-looking statements,” which can be identified by the use of terms such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “estimate”, “intend”, “continue,” “target” or “believe” (or the negatives thereof) or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results or actual performance of the Company and/or the Company’s group may differ materially from those reflected or contemplated in such forward-looking statements. As a result, investors should not rely on such forward-looking statements in making their investment decisions. No representation or warranty is made as to the achievement or reasonableness of and no reliance should be placed on such forward-looking statements.  Potential investors should be aware that any investment in the Company is speculative, involves a high degree of risk and could result in the loss of all or substantially all of their investment. The securities are only suitable for investors who understand the potential risk of capital loss, that there may be limited liquidity in the underlying investments and securities of the Company, for whom an investment in the securities is part of a diversified investment programme and who fully understand and are willing to assume the risks involved in such an investment. This document does not constitute a recommendation concerning the Company’s securities.

This document is limited to and intended for distribution in the United Kingdom only to persons who are qualified investors (within the meaning of Article 2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) who (i) have professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FPO") and/or (ii) are high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2)(a) to (d) of the FPO or to those persons to whom it may otherwise be lawfully communicated (in each case referred to as “Relevant Persons”). This document has not been approved by an authorised person for the purposes of Section 21 of the Financial Services and Markets Act 2000. The information contained in this document is not intended to be viewed by, or distributed or passed on (directly or indirectly) to, and should not be acted upon by, any class of persons other than Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged only with Relevant Persons.

This document is limited to and intended for distribution in the European Economic Area only to persons who are qualified investors (within the meaning of Article 2 of Regulation (EU) 2017/1129).   The Company’s securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or under any securities laws of any state of the United States and may not be offered or sold in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Company does not intend to conduct a public offering of any securities in the United States. Neither this document nor any copy of it may be taken, transmitted or distributed, directly or indirectly, into the United States, its territories or possessions. Any failure to comply with the foregoing restrictions may constitute a violation of U.S. securities laws.  The distribution of this document in jurisdictions other than the United Kingdom may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any restrictions. In particular, neither this document nor any copy of it may be taken or transmitted or distributed or redistributed (directly or indirectly) in the United States, Canada, Japan, Australia, New Zealand or the Republic of South Africa. Any failure to comply with this restriction may constitute a violation of the securities laws of the United States, Canada, Japan, Australia, New Zealand or the Republic of South Africa.